Lincoln Pharmaceuticals Q2 Results
- BSE: 531633
- NSE: LINCOLN
- ISIN: INE405C01035
- Sector: Biotechnology & Drugs
BSE
617.45
-0.05 (-0.01%)
-0.05 (-0.01%)Volume1.93 K
Updated: Mon 25 Nov, 2024 | 15:28:00
NSE
617.8-0.10 (-0.02%)
-0.10 (-0.02%)Volume29.66 K
Updated: Mon 25 Nov, 2024 | 15:29:50
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹161.21 Cr.(9.46%)
- Operating Profit₹25.15 Cr.(28.95%)
- Profit After Tax₹26.33 Cr.(11.23%)
- Operating Margin15.60%(-14.80%)
Note: Comparison is on YoY basis
Quarterly - Lincoln Pharmaceuticals Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 161.21 | 135.62 | -% | 155.99 | -% |
| Selling/ General/ Admin Expenses Total | 27.84 | 26.47 | -% | 24.94 | -% |
| Depreciation/ Amortization | 3.22 | 2.55 | -% | 2.58 | -% |
| Other Operating Expenses Total | 32.71 | 24.59 | -% | 26.07 | -% |
| Total Operating Expense | 136.06 | 117.45 | -% | 127.42 | -% |
| Operating Income | 25.15 | 18.17 | -% | 28.57 | -% |
| Net Income Before Taxes | 34.78 | 25.45 | -% | 36.87 | -% |
| Net Income | 26.33 | 19.01 | -% | 27.65 | -% |
| Diluted Normalized EPS | 13.15 | 9.49 | -% | 13.81 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST